Breaking News Instant updates and real-time market news.

EGRX

Eagle Pharmaceuticals

$46.77

0.15 (0.32%)

06:56
08/09/17
08/09
06:56
08/09/17
06:56

Eagle Pharmaceuticals reports Q2 adjusted EPS 52c, consensus 51c

Reports Q2 revenue $50.1M, consensus $52.52M. Sales of Ryanodex grew 54% to $5.2 during Q2 compared to $3.4M in Q2 2016, and up from $4.4M in 1Q17 and $3.9M during 4Q16, and also added 120 new accounts for a total of 1300 accounts stocking Ryanodex.

  • 09

    Aug

  • 30

    Oct

EGRX Eagle Pharmaceuticals
$46.77

0.15 (0.32%)

05/08/17
PIPR
05/08/17
NO CHANGE
Target $118
PIPR
Overweight
Eagle Pharmaceuticals price target raised to $118 from $90 at Piper Jaffray
Piper Jaffray analyst David Amsellem raised his price target for Eagle Pharmaceuticals to $118 following the company's Q1 results. Eagle's "sustainable" cash flows from Bendeka, along with eventual contribution from Ryanodex in exertional heat stroke and drug-induced hyperthermia, as well as other pipeline assets, position Eagle well for "transformative longer-term earnings growth," Amsellem tells investors in a post-earnings research note. He reiterates an Overweight rating on the shares.
01/12/17
WBLR
01/12/17
NO CHANGE
WBLR
Outperform
Eagle Pharmaceuticals recent selloff overdone, says William Blair
William Blair analyst Tim Lugo views the 26% selloff in shares of Eagle Pharmaceuticals (EGRX) since marketing partner Teva (TEVA) issued 2017 financial guidance as overdone. Teva's outlook included a range of $600M-$660M for Bendeka/Treanda, which reflects expectations of a mid-single-digit volume decrease and no price offsets. The range was below Lugo's expectations by 13%-21%. While negative growth in Bendeka is concerning, with modest pipeline execution, Eagle's shares could see "significant" price appreciation by the end of 2017, Lugo tells investors in a research note. He keeps an Outperform rating on the shares.
01/09/17
MZHO
01/09/17
DOWNGRADE
MZHO
Underperform
Eagle Pharmaceuticals downgraded to Underperform from Neutral at Mizuho
12/21/16
PIPR
12/21/16
NO CHANGE
PIPR
Piper lays out top BioPharma picks for 2017
Piper Jaffray analysts laid out their top BioPharma picks for 2017. Analyst Richard Purkiss favors Pfizer (PFE) and Eli Lilly (LLY) as his top large pharma picks. Analyst Joshua Schimmer calls Gilead (GILD) and Alexion (ALXN) his top large cap picks. Analyst David Amsellem names Horizon Pharma (HZNP) his top specialty pharma pick. Piper's other top Biopharma picks for 2017 include ACADIA (ACAD), Aimmune (AIMT), Akorn (AKRX), Alnylam (ALNY), Axovant Sciences (AXON), Cara Therapeutics (CARA), CoLucid Pharmaceuticals (CLCD), Eale Pharmaceuticals (EGRX), Exelixis (EXEL), Ionis Pharmaceuticals (IONS), Mallinckrodt (MNK), Neurocrine (NBIX), Nektar (NKTR), Otonomy (OTIC), Reata Pharmaceuticals (RETA), Rigel Pharmaceuticals (RIGL), Ignyta (RXDX), Theravance Biopharma (TBPH), Versartis (VSAR) and Voyager Therapeutics (VYGR). The analysts look for recent momentum in BioPharma to continue in 2017. They believe innovation and potentially repatriation should lead to increased merger activity.

TODAY'S FREE FLY STORIES

AXL

American Axle

$13.99

-0.03 (-0.21%)

14:25
08/18/17
08/18
14:25
08/18/17
14:25
Options
American Axle call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$16.11

-0.82 (-4.84%)

14:23
08/18/17
08/18
14:23
08/18/17
14:23
Earnings
Breaking Earnings news story on MiMedx »

MiMedx backs FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

RPM

RPM

$48.24

-0.58 (-1.19%)

14:21
08/18/17
08/18
14:21
08/18/17
14:21
Upgrade
RPM rating change  »

RPM upgraded to Gradually…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$16.11

-0.82 (-4.84%)

14:21
08/18/17
08/18
14:21
08/18/17
14:21
Hot Stocks
MiMedx in pact to divest Stability Biologics, focus on biopharma »

MiMedx Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

$NSD

NASDAQ Market Internals

14:17
08/18/17
08/18
14:17
08/18/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
08/18/17
08/18
14:16
08/18/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRBT

iRobot

$98.82

-3.55 (-3.47%)

14:12
08/18/17
08/18
14:12
08/18/17
14:12
Periodicals
Spruce Point questions iRobot's financial guidance »

Spruce Point Capital says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$16.11

-0.82 (-4.84%)

14:11
08/18/17
08/18
14:11
08/18/17
14:11
Hot Stocks
Breaking Hot Stocks news story on MiMedx »

MiMedx in pact to divest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

GE

General Electric

$24.62

-0.1264 (-0.51%)

14:00
08/18/17
08/18
14:00
08/18/17
14:00
Options
19K GE Oct 27 - Jan 27 call spreads at 20c on ISE »

19K GE Oct 27 - Jan 27…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 02

    Oct

RTNB

root9B Technologies

$0.60

-0.1665 (-21.72%)

14:00
08/18/17
08/18
14:00
08/18/17
14:00
Hot Stocks
Breaking Hot Stocks news story on root9B Technologies »

root9B Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MATX

Matson

$22.53

-6.8159 (-23.22%)

13:56
08/18/17
08/18
13:56
08/18/17
13:56
Hot Stocks
Matson drops after competitor TOTE enters Hawaii trade route »

Matson (MATX), which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$243.52

0.4256 (0.18%)

, SPX

S&P 500

13:51
08/18/17
08/18
13:51
08/18/17
13:51
Periodicals
Breitbart's Pollak tweets '#WAR', after Steve Bannon departs White House »

Senior-editor-at-large…

SPY

SPDR S&P 500 ETF Trust

$243.52

0.4256 (0.18%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEY

KeyCorp

$17.68

-0.115 (-0.65%)

13:50
08/18/17
08/18
13:50
08/18/17
13:50
Options
Short-term call buyers in KeyCorp »

Short-term call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

FB

Facebook

$166.91

-3.09 (-1.82%)

13:46
08/18/17
08/18
13:46
08/18/17
13:46
Hot Stocks
Facebook's Zuckerberg says plans to take two months of paternity leave »

Facebook's Mark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 24

    Aug

  • 13

    Sep

AMC

AMC Entertainment

$12.53

-0.625 (-4.75%)

13:45
08/18/17
08/18
13:45
08/18/17
13:45
Options
AMC Entertainment call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 14

    Sep

  • 27

    Sep

TEVA

Teva

$17.21

0.11 (0.64%)

13:40
08/18/17
08/18
13:40
08/18/17
13:40
Hot Stocks
Teva announces exclusive launch of generic Axiron in the U.S. »

Teva announced the launch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

LGF.A

Lionsgate

$28.25

0.21 (0.75%)

, LGF.B

Lionsgate

$27.18

0.175 (0.65%)

13:37
08/18/17
08/18
13:37
08/18/17
13:37
Hot Stocks
Box Office Battle: 'Annabelle: Creation' to remain in first place »

The major film release…

LGF.A

Lionsgate

$28.25

0.21 (0.75%)

LGF.B

Lionsgate

$27.18

0.175 (0.65%)

TWX

Time Warner

$101.58

-0.03 (-0.03%)

DIS

Disney

$101.02

-0.36 (-0.36%)

VIA

Viacom

$42.40

1.75 (4.31%)

VIAB

Viacom

$29.21

-0.61 (-2.05%)

FOX

21st Century Fox

$26.89

-0.67 (-2.43%)

FOXA

21st Century Fox

$27.35

-0.64 (-2.29%)

SNE

Sony

$38.85

-0.15 (-0.38%)

CMCSA

Comcast

$40.27

-0.97 (-2.35%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 27

    Sep

  • 29

    Sep

MATX

Matson

$22.40

-6.9536 (-23.69%)

13:29
08/18/17
08/18
13:29
08/18/17
13:29
Upgrade
Matson rating change  »

Matson upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYV

Live Nation

$39.06

0.02 (0.05%)

, FB

Facebook

$166.91

-3.09 (-1.82%)

13:28
08/18/17
08/18
13:28
08/18/17
13:28
Hot Stocks
Live Nation drops sharply after Facebook adding ticket sales »

Shares of Live Nation…

LYV

Live Nation

$39.06

0.02 (0.05%)

FB

Facebook

$166.91

-3.09 (-1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 22

    Aug

  • 24

    Aug

  • 13

    Sep

BZUN

Baozun

$33.50

-1.98 (-5.58%)

13:25
08/18/17
08/18
13:25
08/18/17
13:25
Options
Baozun call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

FB

Facebook

$166.91

-3.09 (-1.82%)

, EBAY

eBay

$34.85

-0.51 (-1.44%)

13:20
08/18/17
08/18
13:20
08/18/17
13:20
Periodicals
Facebook adding ticket sales to Marketplace, Recode reports »

Facebook's (FB)…

FB

Facebook

$166.91

-3.09 (-1.82%)

EBAY

eBay

$34.85

-0.51 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 24

    Aug

  • 28

    Aug

  • 29

    Aug

  • 07

    Sep

  • 13

    Sep

PEI

Pennsylvania REIT

$10.11

-0.28 (-2.69%)

, FL

Foot Locker

$34.98

-12.72 (-26.67%)

13:18
08/18/17
08/18
13:18
08/18/17
13:18
Periodicals
Pennsylvania REIT falls after Foot Locker weakness, Bloomberg says »

Shares of Pennsylvania…

PEI

Pennsylvania REIT

$10.11

-0.28 (-2.69%)

FL

Foot Locker

$34.98

-12.72 (-26.67%)

LB

L Brands

$36.28

-1.27 (-3.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

SPX

S&P 500

13:17
08/18/17
08/18
13:17
08/18/17
13:17
Hot Stocks
WH Press Sec.: Kelly, Bannon 'mutually agreed today would be Steve's last day' »

A statement from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

13:17
08/18/17
08/18
13:17
08/18/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
08/18/17
08/18
13:16
08/18/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.